Seeking Alpha

Pharmasset (VRUS +4%) shares are on the move after favorable analyst notes: Piper Jaffray...

Pharmasset (VRUS +4%) shares are on the move after favorable analyst notes: Piper Jaffray initiates coverage at Overweight, and Brean Murray raises its price target to $105 from $87. On top of that, Briefing.com reports hearing that a firm has issued positive comments regarding the company's potential valuation in an M&A scenario.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs